When to Order Imaging for Evaluation of the Symptomatic Male Breast: ACR Appropriateness Decoded

When to Order Imaging for Evaluation of the Symptomatic Male Breast: ACR Appropriateness Decoded

A 58-year-old male presents to your clinic with a palpable lump he noticed in his left breast. It’s slightly tender, and he’s concerned. The differential includes benign gynecomastia, a cyst, or the less common but critical diagnosis of male breast cancer. Your next step is to determine if imaging is warranted and, if so, which modality is most appropriate. Do you start with a mammogram, an ultrasound, or both? Making the right choice avoids unnecessary radiation, reduces patient anxiety, and ensures a timely and accurate diagnosis. This guide breaks down the American College of Radiology (ACR) Appropriateness Criteria for the evaluation of the symptomatic male breast, providing clear, evidence-based recommendations for various clinical scenarios.

What Does ACR Evaluation of the Symptomatic Male Breast Cover?

This ACR topic provides guidance for imaging the male breast in patients presenting with specific symptoms. The criteria apply to men of any age who have a palpable mass, breast tenderness, nipple discharge, nipple retraction, or axillary adenopathy. The guidelines also address the workup of suspected gynecomastia (benign proliferation of glandular tissue) and pseudogynecomastia (fat deposition without glandular growth). The recommendations are stratified by patient age and the nature of the clinical findings—whether they are classic for gynecomastia, indeterminate, or suspicious for malignancy.

These criteria do not apply to asymptomatic screening for male breast cancer, which is not routinely recommended. They also do not cover surveillance imaging for patients with a personal history of breast cancer or those with high-risk genetic mutations (e.g., BRCA1/2) in the absence of new symptoms. The focus is strictly on the initial diagnostic imaging workup for a new breast-related symptom in a male patient.

What Imaging Should I Order for Evaluation of the Symptomatic Male Breast? Recommendations by Clinical Scenario

The appropriate imaging pathway for a symptomatic male patient depends heavily on the clinical presentation and age. The ACR provides specific recommendations to guide this decision-making process, prioritizing diagnostic accuracy while minimizing unnecessary procedures.

For a male patient of any age with symptoms and physical examination findings consistent with gynecomastia or pseudogynecomastia, initial imaging is Usually not appropriate. This includes ultrasound, mammography, and MRI. In cases of classic, bilateral, or concentric subareolar gynecomastia without other suspicious features, a clinical diagnosis is typically sufficient, and imaging can be deferred.

When a palpable mass is indeterminate, age is a key factor. For a male younger than 25 years of age with an indeterminate palpable breast mass, a breast ultrasound is rated Usually appropriate as the initial imaging test. Ultrasound is effective at characterizing masses in younger patients and avoids ionizing radiation. In this age group, diagnostic mammography or digital breast tomosynthesis (DBT) May be appropriate, often as a problem-solving tool if ultrasound findings are equivocal.

For a male 25 years of age or older with an indeterminate palpable breast mass, the recommendation shifts. Diagnostic mammography and digital breast tomosynthesis are both rated Usually appropriate. Mammography is the primary modality for evaluating an indeterminate mass in this population due to the increased incidence of breast cancer with age. A breast ultrasound May be appropriate, typically used to further characterize a finding seen on mammography or to evaluate a palpable mass that is difficult to assess mammographically.

If a male 25 years of age or older undergoes mammography or DBT for an indeterminate mass and the results are indeterminate or suspicious, the next step is clear. A targeted breast ultrasound is Usually appropriate to further characterize the lesion and guide a potential biopsy.

Finally, for a male of any age with physical examination findings suspicious for breast cancer (such as a suspicious palpable mass, axillary adenopathy, nipple discharge, or nipple retraction), a multimodal approach is recommended. Diagnostic mammography, digital breast tomosynthesis, and breast ultrasound are all rated Usually appropriate. This combination provides the most comprehensive initial evaluation, using mammography to assess for calcifications and architectural distortion and ultrasound to characterize the mass and evaluate the axilla.

ACR Imaging Recommendations Table

Adult vs. Pediatric Evaluation of the Symptomatic Male Breast Imaging: Radiation Dose Tradeoffs

The ACR guidelines highlight a critical distinction in the imaging approach based on patient age, primarily driven by the principles of radiation safety and pre-test probability of disease. For males younger than 25, breast cancer is exceedingly rare, and benign conditions like gynecomastia are common. Therefore, the guidelines prioritize a radiation-free modality, making ultrasound (0 mSv) the “Usually appropriate” first-line study. This aligns with the As Low As Reasonably Achievable (ALARA) principle, which is particularly important in younger patients who have a longer lifetime to manifest potential risks from ionizing radiation.

In contrast, for men 25 and older, the lifetime risk of breast cancer, while still low compared to women, begins to increase. In this demographic, the diagnostic value of mammography (which uses a low dose of ionizing radiation, ☢ ☢ 0.1-1mSv) outweighs the small radiation risk. Mammography is superior for detecting suspicious microcalcifications and architectural distortion, which can be early signs of malignancy. Ultrasound is then typically used as an adjunct. This age-based algorithm effectively balances diagnostic yield with radiation safety, tailoring the workup to the most likely diagnoses and risks for each patient group.

Imaging Protocol Details for Evaluation of the Symptomatic Male Breast

Once you’ve decided on the right study, the details of the imaging protocol are essential for obtaining high-quality, diagnostic images. Our protocol guides offer in-depth information on technique, contrast administration, and interpretation principles for key imaging studies. While MRI is not a first-line tool for the initial evaluation of a symptomatic male breast, it may be used in specific circumstances, such as for staging in a newly diagnosed cancer. You can find detailed procedural information in our reference library.

• MRI Breast With and Without Contrast

Tools to Help You Order the Right Study

Navigating imaging guidelines can be complex. GigHz provides a suite of tools designed to support clinical decision-making and streamline the ordering process, ensuring your patients receive the most appropriate care based on the latest evidence.

The ACR Appropriateness Criteria Lookup tool provides direct access to the full library of ACR guidelines, covering hundreds of clinical scenarios beyond the symptomatic male breast. It’s a fast way to verify the right imaging test for nearly any clinical presentation.

For detailed procedural information, the Imaging Protocol Library offers standardized, evidence-based protocols for a wide range of imaging studies. This resource helps ensure that once a study is ordered, it is performed with the correct technique for optimal diagnostic quality.

When discussing imaging options that involve ionizing radiation, the Radiation Dose Calculator is an invaluable tool. It helps you estimate and track cumulative radiation exposure for your patients, facilitating informed conversations about the risks and benefits of different imaging pathways.

Why is imaging not usually recommended for classic gynecomastia?

For patients with a clinical presentation classic for gynecomastia (e.g., bilateral, symmetric, palpable, and tender subareolar breast tissue), the diagnosis can often be made confidently on physical exam alone. In these cases, the pre-test probability of malignancy is extremely low, and the findings on imaging would almost certainly be benign. Proceeding directly to imaging adds cost and potential for incidental findings without changing management. Imaging is reserved for cases where the presentation is atypical, such as a unilateral mass, an eccentric (non-subareolar) location, or the presence of other suspicious features like skin changes or nipple discharge.

What is the role of MRI in evaluating the male breast?

According to the ACR criteria for initial evaluation of a symptomatic male breast, breast MRI is “Usually not appropriate.” Its primary role is not in the initial diagnostic workup of a palpable lump. However, MRI can be valuable in specific, secondary scenarios. For example, it may be used for local staging after a cancer diagnosis to assess the extent of disease, check for chest wall invasion, or evaluate the contralateral breast. It can also be a problem-solving tool in complex cases, such as evaluating for recurrent disease or assessing patients with breast implants.

When should I biopsy a male breast mass?

A biopsy should be considered whenever imaging findings are indeterminate or suspicious for malignancy. Using the BI-RADS (Breast Imaging Reporting and Data System) classification, lesions categorized as BI-RADS 4 (Suspicious) or BI-RADS 5 (Highly Suggestive of Malignancy) warrant a biopsy. A BI-RADS 3 (Probably Benign) finding may be followed with short-interval imaging, though biopsy may be considered depending on the clinical context and patient preference. The decision is typically made by the radiologist in consultation with the referring clinician. Ultrasound-guided core needle biopsy is the standard method for sampling suspicious solid masses.

What is the difference between gynecomastia and pseudogynecomastia?

Gynecomastia is the proliferation of benign glandular breast tissue, which feels firm and rubbery and is typically located directly beneath the nipple-areolar complex. Pseudogynecomastia, on the other hand, is an accumulation of fatty tissue (adipose) in the breast area without any glandular proliferation. It feels softer and is more diffuse. While a physical exam can often differentiate the two, imaging can provide a definitive distinction. On mammography, gynecomastia appears as a density, whereas pseudogynecomastia appears as radiolucent fat. Ultrasound can also clearly distinguish glandular tissue from fat.

Why is ultrasound the first choice for men under 25?

Ultrasound is the preferred initial imaging modality for men under 25 with an indeterminate breast mass for two main reasons. First, breast cancer is exceptionally rare in this age group, so the primary goal is to characterize what is most likely a benign finding. Ultrasound is excellent for differentiating solid masses from cysts and evaluating benign features. Second, ultrasound does not use ionizing radiation. Given the very low risk of cancer, avoiding radiation exposure in a young patient is a key consideration and aligns with the ALARA (As Low As Reasonably Achievable) principle of radiation safety.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 12, 2026